Glycopegylation methods and proteins/ peptides produced by the methods

Details for Australian Patent Application No. 2004236174 (hide)

Owner Novo Nordisk A/S

Inventors Hakes, David; De Frees, Shawn; Bayer, Robert; Bowe, Caryn; Chen, Xi; Zopf, David

Agent Pizzeys

Pub. Number AU-B-2004236174

PCT Pub. Number WO2004/099231

Priority 10/411,044 09.04.03 US; 10/411,037 09.04.03 US; 10/411,012 09.04.03 US; 10/410,897 09.04.03 US; 10/410,980 09.04.03 US; 10/411,043 09.04.03 US; 10/410,930 09.04.03 US; 10/410,945 09.04.03 US; 10/411,049 09.04.03 US; 10/410,962 09.04.03 US; 10/410,913 09.04.03 US; 10/410,997 09.04.03 US; 10/411,026 09.04.03 US

Parent 2002360264

Filing date 9 April 2004

Wipo publication date 18 November 2004

Acceptance publication date 2 June 2011

International Classifications

C07K 1/00 (2006.01) General processes for the preparation of peptides

A61K 38/00 (2006.01) Medicinal preparations containing peptides

A61K 38/21 (2006.01) Medicinal preparations containing peptides - Interferons

A61K 38/22 (2006.01) Medicinal preparations containing peptides - Hormones

A61K 38/27 (2006.01) Medicinal preparations containing peptides - Growth hormone (GH) (Somatotropin)

A61K 38/28 (2006.01) Medicinal preparations containing peptides - Insulins

A61K 38/46 (2006.01) Medicinal preparations containing peptides

A61K 38/48 (2006.01) Medicinal preparations containing peptides

A61K 38/55 (2006.01) Medicinal preparations containing peptides - Protease inhibitors

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 47/48 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates

A61P 1/16 (2006.01) Drugs for disorders of the alimentary tract or the digestive system

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/10 (2006.01) Drugs for disorders of the endocrine system

A61P 7/04 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 7/06 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 19/10 (2006.01) Drugs for skeletal disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/04 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/10 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/16 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

6 October 2005 PCT application entered the National Phase

  PCT publication WO2004/099231 Priority application(s): WO2004/099231

23 April 2009 Assignment before Grant

  Neose Technologies, Inc. The application has been assigned to Novo Nordisk A/S

2 June 2011 Application Accepted

  Published as AU-B-2004236174

29 September 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004236195-Phenyl substituted cyclic derivatives

2004236173-Substituted carboxylic acids